絞り込み

16610

広告

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.

著者 Gerson LB , Robbins AS , Garber A , Hornberger J , Triadafilopoulos G
Am J Gastroenterol.2000 Feb ; 95(2):395-407.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Department of Medicine, Stanford University School of Medicine, California, USA.

スターを付ける スターを付ける     (121view , 0users)

Full Text Sources

Medical

Other Literature Sources

Patients who have uncomplicated gastroesophageal-reflux disease (GERD) typically present with heartburn and acid regurgitation. We sought to determine the cost-effectiveness of H2-receptor antagonists (H2RAs) and proton-pump inhibitors (PPIs) as first-line empiric therapy for patients with typical symptoms of GERD.
PMID: 10685741 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード